Proqr Therapeutics
(PRQR)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2025 | 06-2025 | 03-2025 | 12-2024 | 09-2024 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -38,882 | -25,267 | -10,618 | -30,042 | -20,296 |
| Depreciation Amortization | 2,366 | 1,536 | 714 | 2,988 | 2,298 |
| Other Working Capital | -12,828 | -8,968 | -7,081 | -14,353 | -13,988 |
| Other Operating Activity | 3,250 | 1,823 | 341 | 2,027 | 2,248 |
| Operating Cash Flow | $-46,094 | $-30,876 | $-16,643 | $-39,381 | $-29,739 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -577 | -369 | -236 | -1,534 | -1,413 |
| Other Investing Activity | 0 | 0 | 0 | -2,873 | 0 |
| Investing Cash Flow | $-577 | $-369 | $-236 | $-4,407 | $-1,413 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 78 | 76 | 71 | 77,758 | 192 |
| Other Financing Activity | -1,524 | -976 | -597 | -1,712 | -1,461 |
| Financing Cash Flow | $-1,446 | $-900 | $-527 | $76,046 | $-1,269 |
| Exchange Rate Effect | -1,590 | -1,505 | -497 | 728 | -44 |
| Beginning Cash Position | 174,643 | 169,608 | 157,401 | 128,689 | 130,770 |
| End Cash Position | 124,936 | 135,957 | 139,498 | 161,674 | 98,305 |
| Net Cash Flow | $-49,708 | $-33,651 | $-17,903 | $32,986 | $-32,465 |
| Free Cash Flow | |||||
| Operating Cash Flow | -46,094 | -30,876 | -16,643 | -39,381 | -29,739 |
| Capital Expenditure | -577 | -369 | -236 | -1,534 | -1,413 |
| Free Cash Flow | -46,672 | -31,245 | -16,879 | -40,915 | -31,152 |